Navigation Links
Ortho Organizers(R) Introduces New Premium Product Line - O2 Select(TM) Orthodontic Instruments
Date:5/8/2008

CARLSBAD, Calif., May 8 /PRNewswire/ -- Ortho Organizers, Inc., a leading manufacturer of orthodontic products and continuing education programs, announces the release of their new premium O2 Select Orthodontic Instruments.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080508/LATH052)

Ortho Organizers President and CEO George W. Guttroff noted, "Ortho Organizers fulfills a critical market demand with the release of O2 Select Orthodontic Instruments. The product line was carefully selected to provide a full range of first-rate instruments for the discerning professional." These orthodontic instruments set the standard in fine tools by following the strictest design guidelines and utilizing the very best material on the market, high-quality surgical-grade German steel forgings with tungsten carbide inserts. Rust and corrosion free tungsten carbide offers superior edge strength for cutting and wire forming efficiency, combined with a remarkably long life. The entire product line of O2 Select Orthodontic Instruments are manufactured right here in America.

This exceptional new line offers an instrument to meet every need, from cutting instruments to wire forming and utility pliers, as well as debonding and band removal tools. All instruments feature a premium box joint hinge and are ergonomically designed for maximum doctor comfort and safety.

About the Company

Ortho Organizers provides a wide range of orthodontic products to the worldwide dental market. The Company sells directly to U.S. practitioners and through an established network of independent dealers in International markets. For more information on Ortho Organizers contact us at: 800.547.2000 or 760.448.8600, via email: usasales@OrthoOrganizers.com or via our Web site at http://www.Ortho
'/>"/>

SOURCE Ortho Organizers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
3. OrthoSynetics(TM) Opens New Data Center, Colocation Facility
4. Bone-growing nanomaterial could improve orthopaedic implants
5. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
6. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
7. Statement of DePuy Orthopaedics, Inc. Regarding Agreement with U.S. Attorneys Office
8. Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
9. Orthofix International Acquires InSWing(TM) Interspinous Process Spacer
10. Stuart Collins Joins OrthoSynetics(TM) as Director, Eastern Region Sales
11. Midwest Orthopaedic Research Foundation Lays Out Global Vision for the Future

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...-- For the third consecutive year, the Barbara Ann... preferred hospital for cancer care in southeast M...earch Corporation. ,, (Logo: http://www.news..., The annual survey was conducted through an email...009. Survey respondents were the primary healthcar...
(Date:11/9/2009)..., however , , MONDAY, Nov. 9 (HealthDa...se breasts have a higher risk of cancer recurrence...reast density has already been linked with an incr...s have suspected that very dense breasts may also ...urrence at the site of the original cancer after l...
(Date:11/9/2009)...ewswire/ -- New Mayo Clinic research has found tha...cally reduces patient hospital stay and recovery t...at the North Central Section of the American Urolo...o: http://www.newscom.com/cgi-bin/prnh/20090105/... and video resources, including excerpts from an i...
(Date:11/9/2009)...re for Preteen Son - ,, PHILADELPHIA, Nov. 9 ... with cancer, the hopeful news is that pediatric s...Among the bad news -- treatments that enable survi...d with cancer who have reached puberty currently h...fore undergoing cancer treatment, they may have th...
(Date:11/9/2009)... WHAT: All PETCO stores nationwide will host a...ated by specially trained in-store nutrition, .... During the 30-minute, workshop, pe...f, their dogs and cats, have a chance... nutrition, receive an assessment of their individ...
Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4
...try,s Leading Study Tool to Expand Profile with Ar... Prep, the massage,industry,s leading study progra... massage school graduates. Beginning in 2008, Area... Prep guarantees passage of the rigorous NCETM and...
...sing Fourth Quarter & Full-Year 2007 Financial Res... 11, 2008, Presenting at the UBS Global Healthcar... February 12, 2008, CINCINNATI, Jan. 28 ... community events., Fourth Quarter & Full-Year 20...
...e number of Russian women who smoke has more than ...cording to new research. , In 1992, seven per cen...by 2003. In the same period, the number of men who...on of the previously state owned tobacco industry ...
...w York, New York The Cancer Research Institute (C...he Cancer Vaccine Consortium, a program of the Sab...borative, a program of the Cancer Research Institu...ed voice in the cancer vaccine field and provides ...
...LE, Jan. 28 Results from Milliman,s third annual,... U.S. variable annuity,(VA) carriers indicate that...some form of GLB., Total sales of VAs that offere...up to 95% during the first,half of 2007, demonstra...
...DO, Fla., Jan. 28 MEDai, Inc., headquartered in,O...hcare solutions,announced that its longstanding Pi... Diego, CA, was awarded the 2007 Malcolm Baldrige ...ce. Congress,established the program in 1987 to re...
Other Medicine News:Health News:Massage Prep(TM) Announces Outreach Program 2Health News:LCA-Vision Announces Upcoming Investment Community Events 2Health News:Number of Russian women smokers has doubled since Soviet collapse 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 2Health News:Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute 3Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 2Health News:Milliman Survey Confirms Continued Dominance of Guarantees in Variable Annuity Retirement Income Products 3Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 2Health News:MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award 3
(Date:11/9/2009)..., Mass., Nov. 9 Caliper ...ovider of tools and services for drug discovery an... Caliper Discovery Alliances and Services (CDAS) u...$1.8 million under its contract with the Environme... screening program. This new task order increases...
(Date:11/6/2009)...Wash., Nov. 6 SCOLR Phar...sults for the three and nine months ended Septembe...a,s President and CEO, said, "We continue to advan...uprofen formulation. Several potential partners ha...nel and external resources as they evaluate the po...
(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...
Breaking Medicine Technology:Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9American Chemical Societys Weekly PressPac June 3 2009 8740 1American Chemical Societys Weekly PressPac June 3 2009 8740 2American Chemical Societys Weekly PressPac June 3 2009 8740 3American Chemical Societys Weekly PressPac June 3 2009 8740 4American Chemical Societys Weekly PressPac June 3 2009 8740 5American Chemical Societys Weekly PressPac June 3 2009 8740 6American Chemical Societys Weekly PressPac June 3 2009 8740 7American Chemical Societys Weekly PressPac June 3 2009 8740 8American Chemical Societys Weekly PressPac June 3 2009 8740 9American Chemical Societys Weekly PressPac June 3 2009 8740 10ViroPharma Announces Appointment of Frank Baldino Jr Ph D to Board of Directors 48170 1ViroPharma Announces Appointment of Frank Baldino Jr Ph D to Board of Directors 48170 2ViroPharma Announces Appointment of Frank Baldino Jr Ph D to Board of Directors 48170 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4
...ering Cancer Center Investigators to Assess BSI-20...r Patients -, BRISBANE, Calif., May 8 BiPar Scie...2 clinical trial programs for its lead,product, BS...clinical trial,of BSI-201 that BiPar has launched ... in breast and brain cancer., The company is eval...
...ferred Induction Dosing Regimen, SEATTLE, May 7 ...y announced that its partner, Wyeth Pharmaceutical...d patient dosing in the next,Phase 2b clinical tri...s,(RA). In collaboration with Trubion, Wyeth Pharm...r CD20-directed products., The randomized, parall...
Other Medicine Technology:BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4
Human Growth Hormone EIA Endocrine Function 025-BC-1033
...of pancreatic b-cell function is not only of use i...l history of diabetes mellitus, but is also releva...choice of treatment. Peripheral insulin levels ca... the large and variable uptake from the portal cir...
Anti-Gliadin IgG & IgA (Ab) EIA Gastrointestinal Markers 027-GD77 Celiac Disease Food Allergy
...n enzymeimmunoassay for the quantitation of 25-OH ...lasma. Calibrators, controls and samples are dilut...es are incubated in microtitre wells which are coa...for 2 hours at room temperature before aspiration ...
Medicine Products: